SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/9DA5818C1C2C0A0796E5178BA434F5E4804DAEF615BF4669D43744F98D87619260868F6D1732E274AC27189FDCEBA07B>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/9DA5818C1C2C0A0796E5178BA434F5E4804DAEF615BF4669D43744F98D87619260868F6D1732E274AC27189FDCEBA07B
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/9DA5818C1C2C0A0796E5178BA434F5E4804DAEF615BF4669D43744F98D87619260868F6D1732E274AC27189FDCEBA07B
http://www.w3.org/2000/01/rdf-schema#comment
"Although anti-Jo1 positive patients with antisynthetase syndrome share features of patients with anti-PL7/PL12 antibody they exhibit many differences regarding clinical phenotype and long-term outcome."
xsd:string
http://purl.uniprot.org/uniprot/#_FB2F56225B555B844F6754BABF6ACA5EF80D69EF9E562D12602FD3342A657C62802CA74C410CE8AB5DE9CF3CD87457DC
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/9DA5818C1C2C0A0796E5178BA434F5E4804DAEF615BF4669D43744F98D87619260868F6D1732E274AC27189FDCEBA07B
http://purl.uniprot.org/uniprot/B4DEA2
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/9DA5818C1C2C0A0796E5178BA434F5E4804DAEF615BF4669D43744F98D87619260868F6D1732E274AC27189FDCEBA07B
http://purl.uniprot.org/uniprot/#_B4DEA2-mappedCitation-22326685
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/9DA5818C1C2C0A0796E5178BA434F5E4804DAEF615BF4669D43744F98D87619260868F6D1732E274AC27189FDCEBA07B